FDA Creates Fecal Transplant Regulations

The FDA has announced that fecal microbiota for transplantation is a biological product and drug, which will require an investigational new drug application to be submitted before use, according to an Infectious Disease Special Addition report.  

FMT is currently used as a treatment for Clostridium difficile infection. The FDA's regulatory actions are intended to protect patients from unnecessary risk.

Many have criticized the FDA for enacting strict regulations of a treatment that, as of yet, has shown little negative consequence.

More Articles on Gastroenterology:
3 Benefits of Outsourcing Colonoscopy Prep
UHC Recruits Dr. Adam Hansen, Gastroenterology Specialists
AbbVie, Galapagos Partner to Test Possible Chrohn's Disease Drug




Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast